Clinical Trial Update: Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing metformin to vildagliptin to reduce progression of complications in metabolic syndrome and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: Cairo University | Conditions: Metabolic Syndrome, Diabete Type 2 | Phase 4 | Status: UNKNOWN